50 clinical presentations and posters highlight benefits of MRI-guided radiation adaptive therapy
DENVER, May 12, 2023 /PRNewswire/ -- ViewRay, Inc. (Nasdaq:VRAY) announced today that the company's MRIdian MRI-guided radiation therapy system will be featured at the Annual Meeting of the European Society for Radiotherapy and Oncology (ESTRO) with over 50 presentations and posters highlighting MRIdian clinical and research experience. This year's ESTRO meeting will be held May 12-16, 2023, in Vienna, Austria.
Read more at prnewswire.com